The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
92181657 9218165 7 F 2000 20160817 20130408 20160822 EXP US-009507513-1304USA002741 MERCK 0.00 M Y 246.00000 KG 20160822 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
92181657 9218165 1 PS PROPECIA FINASTERIDE 1 Oral 1 MG, UNK 20788 1 MG FILM-COATED TABLET
92181657 9218165 2 SS PROSCAR FINASTERIDE 1 Oral 5 MG CUT INTO SMALLER DOSES 0 FILM-COATED TABLET
92181657 9218165 3 SS FINASTERIDE. FINASTERIDE 1 Oral 1 MG, UNK U 0 1 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
92181657 9218165 1 Alopecia
92181657 9218165 2 Alopecia
92181657 9218165 3 Alopecia

Outcome of event

Event ID CASEID OUTC COD
92181657 9218165 OT
92181657 9218165 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
92181657 9218165 Agitation
92181657 9218165 Anxiety
92181657 9218165 Asthenia
92181657 9218165 Benign prostatic hyperplasia
92181657 9218165 Blood testosterone decreased
92181657 9218165 Cognitive disorder
92181657 9218165 Colectomy
92181657 9218165 Depression
92181657 9218165 Diverticulitis
92181657 9218165 Drug abuse
92181657 9218165 Drug administration error
92181657 9218165 Ejaculation disorder
92181657 9218165 Encephalopathy
92181657 9218165 Erectile dysfunction
92181657 9218165 Gynaecomastia
92181657 9218165 Haematuria
92181657 9218165 Hypercholesterolaemia
92181657 9218165 Hypogonadism
92181657 9218165 Implant site erythema
92181657 9218165 Libido decreased
92181657 9218165 Nephrolithiasis
92181657 9218165 Obesity
92181657 9218165 Respiratory failure
92181657 9218165 Rhabdomyolysis
92181657 9218165 Sexual dysfunction
92181657 9218165 Sleep apnoea syndrome
92181657 9218165 Testicular failure
92181657 9218165 Urinary tract disorder
92181657 9218165 Wrong technique in product usage process

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
92181657 9218165 1 20000317 20070412 0
92181657 9218165 2 20000317 20070412 0
92181657 9218165 3 20000317 20070412 0